US Stem Cell Inc (USRM)

[Zues]

If the appeals court sides with USRM it will be the same suit just kicked back to district court for retrial. You bring up an interesting question about the plaintiff and rewording. It is entirely possible the FDA changes their language and tactics for the bench trial. The FDA might feel they need a different approach to win.

I am convinced a bench trail will happen. But I will not feel as optimistic about things if Ungaro is the presiding judge. I think she is bias or even worse.